Robert W. Lee, Ph.D., provides direction for product and business development for Lubrizol Life Science, Health – CDMO Division (LLS). Before joining LLS, Rob held senior management positions at Novavax, Lyotropic Therapeutics, and Imcor. He was one of the founding scientists at NanoSystems, built and led their Analytical Sciences Department and after NanoSystems was acquired by élan, built and was head of élan’s Sterile Products Department. He holds BSs in Biology and Chemistry from the University of Washington and a PhD in Physical Bioorganic Chemistry from the University of California, Santa Barbara.
Rob has published articles in numerous peer-reviewed journals and six book chapters plus holds over two dozen issued patents or provisional patent applications. He has more than 33 years of experience in the pharmaceutical industry, specializing in scientific and corporate management, commercial manufacturing, and business development. His technical specialties include CMC, therapeutic drugs, and diagnostic imaging agents.